Ocugen, Inc. to Present at H.C. Wainwright Global Investment Conference
MALVERN, Pa., May 23, 2022 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals and vaccines, today announced that Dr. Shankar Musunuri, Chairman, CEO and Co-Founder of Ocugen, will participate in an in-person fireside chat at the H.C. Wainwright Global Investment Conference, on May 24, 2022, at 1:30pm ET in Miami Beach, Florida.
Registration is available for those who want to watch the presentation virtually. A replay of the fireside chat will be available through the Investor’s section of the Ocugen website starting on May 24 and for approximately 90 days following the conference.
About Ocugen, Inc.
Cautionary Note on Forward-Looking Statements
For investor-related inquiries: [email protected]